SCHEMBL6867232

SCHEMBL6867232

CN(C)c1ccnc(N[C@H]2CC[C@@H](NC(=O)Nc3ccccc3C(C)(C)C)CC2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 3/20 0.49
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 1/20 0.41
MAPK8 P45983 2/20 0.40
AURKB Q96GD4 1/20 0.40
MAPK14 Q16539 1/20 0.40
MCHR1 Q99705 5/20 0.40
MAPK9 P45984 2/20 0.39
CYP2C9 P11712 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
MAPK10 P53779 1/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CDK7 P50613 1/20 0.39
CDK9 P50750 1/20 0.39
ADRA2A P08913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867237 1.00 P2RY1 (0.49) P2RY1KDM4ETDP1LMNAMAPK8
SCHEMBL6878016 0.91 EPHX2 (0.45) P2RY1TDP1MAPK14MCHR1CYP2C9
SCHEMBL6878023 0.91 EPHX2 (0.45) P2RY1TDP1MAPK14MCHR1CYP2C9
SCHEMBL6460789 0.89 MCHR1 (0.42) P2RY1KDM4ETDP1MAPK8MAPK14
SCHEMBL6460783 0.89 MCHR1 (0.42) P2RY1KDM4ETDP1MAPK8MAPK14
SCHEMBL6872853 0.87 EPHX2 (0.47) MAPK8AURKBMAPK14MCHR1MEN1
SCHEMBL6872847 0.87 EPHX2 (0.47) MAPK8AURKBMAPK14MCHR1MEN1
SCHEMBL6869279 0.86 MAPK14 (0.54) MAPK8AURKBMAPK14MCHR1HTT
SCHEMBL6878450 0.86 MAPK8 (0.41) KDM4EMAPK8AURKBMAPK14MCHR1
SCHEMBL6869275 0.86 MAPK14 (0.54) MAPK8AURKBMAPK14MCHR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed